CD137L-DC-EBV-VAX (National University Hospital)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCD137L-DC-EBV-VAX (National University Hospital)

Drug Alias NameCD-137L-DC-EBV-VAX

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNasopharyngeal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesNational University Hospital

Inactive CompaniesN/A

Active IndicationsNasopharyngeal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A